Cargando…
Suppression of SMOC2 alleviates myocardial fibrosis via the ILK/p38 pathway
BACKGROUND: Fibrosis of the myocardium is one of the main pathological changes of adverse cardiac remodeling, which is associated with unsatisfactory outcomes in patients with heart disease. Further investigations into the precise molecular mechanisms of cardiac fibrosis are urgently required to see...
Autores principales: | Rui, Huang, Zhao, Fang, Yuhua, Lei, Hong, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017443/ https://www.ncbi.nlm.nih.gov/pubmed/36935650 http://dx.doi.org/10.3389/fcvm.2022.951704 |
Ejemplares similares
-
Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation
por: Chen, Zhi-Teng, et al.
Publicado: (2021) -
SMOC1 silencing suppresses the angiotensin II-induced myocardial fibrosis of mouse myocardial fibroblasts via affecting the BMP2/Smad pathway
por: Wang, Yize, et al.
Publicado: (2018) -
Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021) -
EGCG Alleviates Obesity-Induced Myocardial Fibrosis in Rats by Enhancing Expression of SCN5A
por: Yi, Haoan, et al.
Publicado: (2022) -
Blockade of the Notch Signaling Pathway Promotes M2 Macrophage Polarization to Suppress Cardiac Fibrosis Remodeling in Mice With Myocardial Infarction
por: Li, Zhi, et al.
Publicado: (2022)